Epidemiology of genital herpes - Recent advances

European Journal of Dermatology

Volumn 9, Issue 3, 1999, Pages 177-184

  Halioua, B ^a   Malkin, J E ^a  

^a INSTITUT ALFRED FOURNIER   (France)

Author keywords

Epidemiology; Genital; Herpes; HSV 2; Sexually transmitted disease

Indexed keywords

VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ARTICLE; GENITAL HERPES; GENITAL ULCER; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; RISK FACTOR; SEROEPIDEMIOLOGY; SEROPREVALENCE; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; VIRUS SHEDDING; VIRUS TRANSMISSION;

AGE FACTORS; FEMALE; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; SEXUAL PARTNERS;

EID: 0032903880     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (91)

1. 1. Stamm WE, Handsfield H, Rompalo AM, et al. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988; 260: 1429-33.
2. 2. Holmberg SD, Stewart JA, Gerber AR, et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988; 259: 1048-50.
3. 3. Marchant J, Roe A. Genital herpes: recognizing and addressing patients' needs. Herpes J 1997; 4: 36-41.
4. 4. Kampmeier RH. Herpes genitalis: a clinical puzzle for two centuries. Sex Trans Dis 1984; 11: 41.
5. 5. Oates JK. Venereal disease genital herpes. J. Hosp Med 1983; 6: 13-9.
6. 6. Slavin HB, Gavett E. Primary herpetic vulvovaginitis. Proc Soc Exp Biol Med 1946; 63: 343.
7. 7. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral O, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337: 1105-11.
8. 8. Corey L, Spear PG. Infections with herpes simplex viruses. N Engl J Med 1986; 314: 686-91.
9. 9. Nahmias AJ, Roizman B. Infection with herpes simplex virus 1 and 2. N Engl J Med 1973; 189: 667-74.
10. 10. Prober CG. Herpetic vaginitis 1993 [Review] [19 refs]. Clin Obst Gynecol 1993; 36 (1); 177-87.
11. 11. Mertz GJ, Schmidt JL, Guinan ME, Winter C, Holmes KK, et al. Frequency of acquisition of first episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Trans Dis 1985; 12: 33-9.
12. 12. Mertz GJ, Benedetti J Ashley R, Selkes SA, Corey L. Risk and factors for sexual transmission of genital herpes. Ann Intern Med 1992; 116: 197-202.
13. 13. Mertz GJ, Coombs RW, Ashley R, Jourden J, Remington M, Winter C, et al. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective. J Infect Dis 1988; 157: 1169-77.
14. 14. Bryson Y, Dillon M, Bernstein DI, Radolf J, Zakowski P, Garratty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple. J Infect Dis 1993; 167: 942-6.
15. 15. Nader SN, Prober CG. Herpes virus infections of the vulva. Sem Derm 1996; 15 (1): 8-16.
16. 16. Corey L. The current trend in genital herpes:progress in prevention. Sex Trans Dis 1994; 21: S38-44.
17. 17. Prober CG, Corey L, Brown ZA, Hensleigh PA, Frenkel LM, Bryson XJ, Whitley RJ, and Arvin AM. The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis 1992; 15: 1031-8.
18. 18. Koutsky L, Ashley R, Holmes K, Stevens CE, Critchlow CW, Kiviat N, et al. The frequency of unrecognised type 2 herpes simplex virus infection among women: implications for the control of genital herpes. Sex Trans Dis 17: 90-4.
19. 19. Breinig MK, Kingsley LA, Armonstrong JA, Freeman DJ, Ho M. Epidemiology of genital herpes in Pittsburg: serological, sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis 162: 306-12.
20. 20. Siegel D, Golden E, Washington E, Morse SA, Fullilove MT, Catania JA, et al. Prevalence and correlates of herpes simplex infections: a population-based AIDS in multiethnic neighborhoods study. JAMA 1992; 268: 1702-8.
21. 21. Cowan F, Johnson AM, Ashley R, Corey L, Mindel A. Is HSV-2 antibody a good serological marker of sexual lifestyle - results of a cross-sectional survery of blood donors. BMJ 1994; 309: 1325-9.
22. 22. Mertz GJ. Epidemiology of genital herpes infections [Review] [39 refs]. Infect Dis Clin North America 1993; 7 (4): 825-39.
23. 23. Koelle DM, Benedetti J, Langenberg A, et al. Asymptomatic reactivation of herpes simplex virus in women after first episode of genital herpes. Ann Intern Med 1992; 116: 433-7.
24. 24. Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and symptomatic genital herpes infection. N Engl J Med 1995; 333: 770-5.
25. 25. Straus SE, Seidlin M, Takiff HE, et al. Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpes. Sex Trans Dis 1989; 16: 107-13.
26. 26. Strand A, Vahine A, Svennerholm B, et al. Asymptomatic virus shedding in men with genital herpes infection. Scand J infect Dis 1986; 18: 195-7.
27. 27. Deture FA, Drylie DM, Kaufman HE, et al. Herpes virus type 2: study of semen in male subjects with recurrent infections. J Urol 1978; 120: 449-51.
28. 28. Moore DE, Asley RL, Zaruskie PW, et al. Transmission of genital herpes by donor insemination. JAMA 1989; 261: 3441-3.
29. 29. Wald A, Taylor L, Warren T, et al. Subclinical shedding of herpes simplex virus in men with genital herpes [abstract H111]. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1995 Sept. 17-20; San Francisco, USA.
30. 30. Guinan ME, Wolinsky SM, Reichman RC. Epidemiology of genital herpes simplex virus infection. Epidemiol Rev 1985; 7: 127-46.
31. 31. Lavoie SR, Kaplowitz LG. Management of genital herpes infection. Sem Derm 1994; 13 (4): 248-55.
32. 32. Pereira FA. Herpes simplex: evolving concepts. J Am Acad Dermatol 1996; 35: 503-20.
33. 33. Ashley R, Cent A, Maggs V, et al. Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus type 1 and 2. Ann Intern Med 1991; 115: 520-6.
34. 34. Ashley R. Laboratory techniques in the diagnosis of herpes simplex infection. Genitourin Med 1993; 64: 174-83.
35. 35. Nader SN, Pober CG. Herpes virus infections of vulva and vagina. In: Elsner P, Martius J, Martius J, editors. Vulvovaginitis. New York; Dekker; 1993: 229-73.
36. 36. Bernstein DI, Bryson YJ, Lovette MA. Antibody response to type-common and type-unique epitopes of herpes simplex virus polypeptides. J Med Virol 1985; 15: 251.
37. 37. Safrin S, Arvin A, Mills J, Ashley R. Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS. J Clin Microbiol 1992; 30: 1312-4.
38. 38. Ashley RL, Militoni J, Lee F, Nahimas AJ, Corey L. Comparison of Western blot (immunoblot), and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus type 1 et 2 in human sera. J Clin Microbiol 1988; 26: 662-7.
39. 39. Svennerholm B, Olofsson S, Jeansson S, Vahlne A, Lycke E. Herpes simplex virus type selective enzyme linked immunosorbent assay with helix pomatia lectin-purified antigens. J Clin Microbiol 1984; 19: 235-9.
40. 40. Lee FK Coleman M, Pereira L, Bailey PD, Tatsuno M, Nahmias AJ. Detection of herpes simplex virus type 2 specific antibody with glycoprotein G. J Clin Microbiol 1985; 22: 641-4.
41. 41. Lee FK, Pereira L, Griffi C, Reid E, Nahmias AJ. A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies. J Virol Meth 1986; 14: 111-8.
42. 42. Ho DWT, Fiel PR, Sjogren-Jansson E, Jeansson S, Cunningham AL. Indirect ELISA or the detection of HSV-2 specific IgG and IgM antibodies with glycprotein G (gG-2). J Virol Meth 1992; 36: 249-64.
43. 43. Ho DWT, Field PR, Irving WL, Packham DR, Cunningham AL. Detection of immunoglobulin-M antibodies to glycoprotein G-2 by Western blot (immunoblot) for diagnosis of initial herpes simplex virus type-2 genital infections. J Clin Microbiol 1993; 31: 3157.
44. 44. Sullender WM, Yasukawa LL, Schwartz M, et al. Type specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to HSV-2 infection at delivery, and infants with neonatal herpes. J Infect Dis 1988; 157: 164-7.
45. 45. Kulhanjian JA, Soroush V, Au DS, et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 1992; 326: 916-20.
46. 46. Whitley RJ, Gnann JW. The epidemiology and clinical manifestations of herpes simplex virus infections. In: Roizman BRJ. The human herpes virus. New York: Raven Press; 1993: 69-105.
47. 47. Hashido M, Kawana T, Tsugemi H, et al. The prevalence of type-specific antibodies to herpes simplex virus type 2 in Japan. Igaku-np-ayumi 1990; 152: 669-70.
48. 48. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1983; 69 (suppl.): 19-36.
49. 49. Cunningham AL, Lee FK, Ho DWT, et al. Herpes simplex virus type-2 antibody in patients attending antenatal or STD clinics. Med J Aust 1993; 158: 525-8.
50. 50. Field PR, Ho DWT, Cunningham AL. Prevalence of herpes simplex virus type 2 (HSV-2) antibody in blood donors and children and patients attending antenatal an STD clinics in Sydney [Abstract]. ASH Annual Scientific 1993.
51. 51. Forsgren M, Skoog E, Jeansson, et al. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications For STD epidemiology. Int J STD AIDS 1994; 5: 113-6.
52. 52. Gibson JJ, Hornung CA, Alexander GR, et al. A cross-sectional study of herpes simplex virus type 1 and 2 in college students: occurence and determinants of infection. J Infect Dis 1990; 162: 306-12.
53. 53. Johnson RE, Lee F, Hadgu A, McQuillian G, Aral SO, Keesling S, et al. US genital herpes trends during the first decade of AIDS: prevalences increased in young whites and elevated in blacks. Sex Trans Dis 1994; 21 (suppl.): S109.
54. 54. Kinghorm GR. Limiting the spread of genital herpes. [Review] [39 refs]. Scand J Infect Dis (suppl.) 1996; 100: 20-5.
55. 55. Ades AE, Peckham CS, Dale GE, Best JM, Jeansson S. Prevalence of antibodies to herpes simplex virus type 1 et 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health 1989; 43: 53-60.
56. 56. Nahmias AJ, Roizman B. Infection with herpes simplex virus 1 and 2. N Engl J Med 1973; 289: 667-74.
57. 57. Omar Lupi da Rosa Santos. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 in Brazil [Poster 136]. In: 54th Annual Meeting of the American Academy of Dermatology, Washington, DC., p. 18.
58. 58. Christenson B, Bottinger M, Svensson A, Jeansson S. A 15 year surveillance study of antibodies to herpes simplex virus type 1 et 2 in a cohort of young girls. J Infect Dis 1992; 25: 147-54.
59. 59. Siegel D, Golden, Washington AE, et al. Prevalence and correlates of herpes simplex infections: the population-based AIDS in multiethnic neighborhoods study. JAMA 1992; 268: 1702-8.
60. 60. Stavraky KM, Rawls WE, Chiavetta J, Donner AP, Wanklin JM. Sexual and socioeconomic factors affecting the risk of past infections with herpes simplex virus type 2. Am Epidemiol 1983; 1: 109-21.
61. 61. Oberle MW, Rosero-Bixny L, Lee FK, et al. Herpes simplex virus type 2 antibodies: high prevalence in monogamous women in Costa Rica. Am J Trop Med Hyg 1989; 41: 224-9.
62. 62. Curtis P, Okin M, McGaghie WC, Resnick J Joseph M, and Davis G. A pilot study of the prevalence of herpes genitalis among selected groups of patients seeking 9 care in a family practice center. Fam Med 1990; 22: 458-61.
63. 63. Swanson, et al. Gender differences in risk behaviors. Public Health Nursing 1955; 12 (2): 107.
64. 64. Kinghorn GR. Epidemiology of genital herpes. J Int Med Res 1994; 22 (suppl. 1): 14-23A.
65. 65. Slomka MJ. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus. [Review] [35 refs]. Communicable Disease Report. CDR Review. 1996; 6 (3): R41-5.
66. 66. Stone KM, Grimes DA, Magder LS. Primary prevention of sexually transmitted diseases: a primer for clinicians. JAMA 1986; 255: 763-6.
67. 67. Bonchet F, Yasukawa I, Bronzan R, et al. A prospective evaluation of primary genital HSV2 infection acquired during pregnancy. Ped Inf Dis 1990; 9: 499-504.
68. 68. Swanson JM, Remy L, Chenitz C, Chastain R, Trocki K. Illicit drug use in young adults with genital herpes. Public Health Nursing 1993; 10: 197-203.
69. 69. Kemeny ME, Cohen F, Zegans LS, Conant MA. Psychological and immunological predictors of genital herpes recurrence. Psychosom Med 1989; 51: 195-208.
70. 70. Ross JDC, Smith IW, Elton RA. The epidemiology of herpes simplex virus type 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin Med 1993; 69: 381-3.
71. 71. White C, Wardropper A. Genital herpes simplex infection in women. Clin Derm 1997; 15: 81-91.
72. 72. Laffertv WE, Coombs RVV, Benedetti J, et al. Recurrences after oral and genital herpes simplex virus infection: influence of site of infection and viral type and antibody response. N Engl J Med 1987; 316: 1444-9.
73. 73. Reeves WC, Corey L, Adams HG, et al. Risk of recurrence after first episodes of genital herpes: relation to HSV type and antibody response. N Engl J Med 1981; 305: 315-9.
74. 74. Mindel A, Weller IV, Faherty A, Sutherland S, Fiddian AP, Adler MW. Acyclovir in first attacks of genital herpes and prevention of recurrences. Genitouri Med 1986; 62: 28-32.
75. 75. Corey L, Mindel A, Fife KH, Sutherland S, Benedetti J, Adler MW. Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir. Sex Trans Dis 1985; 12: 215-8.
76. 76. Bernstein DI. Effects of prior HSV-1 infection on genital HSV-2 infection. Prog Med Virol 1991; 38: 109-27.
77. 77. Mertz GJ, Ashley R, Burke RL, et al. Double-blind placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection. J Inf Dis 1990; 161: 653-60.
78. 78. Corey L, Adams HG, Brown ZA, et al. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983; 98: 958-72.
79. 79. Prober CG, Arvin AM. Genital herpes and the pregnant woman. (Remington and Scwartz). Curr Clin Top Infect Dis 1989; 10: 1-26.
80. 80. Mertz G. Herpes simplex virus. In: Galasso G, Whitely R, Merigan T, editors. Antiviral Agents and Viral Diseases in Man. 3rd ed. New York: Raven Press; 1990.
81. 81. Mindel A. Recent advances in genital herpes. Ann Acad Med Singapore 1995; 24: 584-92.
82. 82. Telzak EE, Chiasson MA, Bevier PJ, Stoneburner RL, Castro KG, Jaffe HW. HIV-1 seroconversion in patients with and without genital ulcer disease: a prospective study. Ann Intern Med 1993; 119: 1181-6.
83. 83. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989; 2: 403-7.
84. 84. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163: 233-9.
85. 85. Kassler WJ, Zenilman JM, Erickson B, Fox R, Peterman TA, Hook EW III. Seroconversion in patients attending sexually transmitted disease clinics. AIDS 1994; 8: 351-5.
86. 86. Wasserheit JN. Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19: 61-77.
87. 87. Schafer SL, Vlach J, Pitha P. Cooperation between herpes simplex virus type 1 encoded ICPO and Ta to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site. J Virol 1996; 70: 6937-46.
88. 88. Ghosh S, Sleby MJ, Peterlin BM. Synergism between Tat and VP16 in transactivation of HIV-1 LTR. J Mol Biol 1993; 234: 610-9.
89. 89. Fauci AS. The human immunodeficiency virus infection and mechanism of pathogenesis. Science 1988; 239: 617-9.
90. 90. Kassler WJ, Zenilman JM, Erickson B, et al. Seroconversion in patients attending sexually transmitted disease clinics. AIDS 1994; 8: 351-5.
91. 91. Fennema JS, Van Ameijde EJ, Coutinho RA, Van Den Hoek AA. HIV sexually transmitted diseases and gynecologic disorders in women: increased risk for genital herpes and warts among HIV-infected prostitutes in Amsterdam. AIDS 1995; 9 (9): 1071-8.